NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080220032

Registered date:06/09/2005

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedPrimary cervical cancer patients treated with radiotherapy
Date of first enrollment06/09/2005
Target sample size240
Countries of recruitment
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : Z-100 INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Injection

Outcome(s)

Primary OutcomeSurvival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum<= 79age old
GenderFemale
Include criteriaInclusion Criteria: -Patients with FIGO Stage IIb - IVa. -Patients with squamous cell carcinoma histologically. Exclusion Criteria: -Patients with complication of cancers in addition to cervical cancer or patients who undergo the therapy. -Patients who contracted the cancers except for cervical cancer within 5 years.
Exclude criteria

Related Information

Contact

Public contact
Name
Address kaihatu@zeria.co.jp
Telephone
E-mail
Affiliation ZERIA Pharmaceutical Co.,Ltd.
Scientific contact
Name
Address
Telephone
E-mail
Affiliation